Fight over COVDI-19 vaccine booster shots heats up as cases surge in areas with low vaccination rates - CBS News
The FDA on Wednesday released new documents from Pfizer ahead of an advisory panel meeting scheduled for Friday to discuss COVID booster shots.The documents claim that protection from Pfizer's vaccine loses some effectiveness after six months but improves to 95% after a third dose.
In a separate document, FDA staff noted they have yet to verify some data that would support an additional dose, saying the current vaccines "still afford protection against severe COVID-19 disease and death in the United States.".